Cancer is always scary, but few diagnoses carry as much weight as triple negative breast cancer (TNBC). Accounting for 10 to ...

Adding everolimus to carboplatin was associated with significantly increased progression-free survival (PFS) among patients with advanced triple-negative breast cancer (TNBC), according to a recent ...

A national cohort study found that the incidence of triple-negative breast cancer (TNBC) is highest among Black women living in the most socioeconomically disadvantaged neighborhoods, and the ...

Improvements seen in PFS, OS with Dato-DXd for previously untreated, locally recurrent inoperable or metastatic TNBC.

Triple negative breast cancer (TNBC) represents approximately 10-15% of all breast cancer diagnoses but accounts for a disproportionately high percentage of breast cancer deaths. What sets this ...

Triple negative breast cancer wreaks a particularly heavy toll in certain regions and populations, with stark differences in both incidence and survival rates across geographical lines. Recent studies ...

Triple Negative Breast Cancer (TNBC) is one of the most aggressive types of breast cancer. It’s the kind of breast cancer that doesn’t have estrogen receptors, progesterone receptors, and human ...

Breakthrough combinations: Pairing immunotherapy with targeted antibody-drug conjugates is showing improved survival rates for TNBC patients. Why TNBC is tough: Lacking key hormone and HER2 markers, ...

Company Plans to Initiate First-in-Human Phase 1/2 Trial in 1H 2026, Anchored by a Leading U.S. Academic Medical ...

As a child, I sometimes joined my father on rounds at his hospital in Rio de Janeiro. There, I witnessed the power of medicine to transform lives. His compassion for patients influenced my own love ...

Although improvements in breast cancer treatment have led to decreases in mortality, patients with triple-negative breast cancer (TNBC), or tumors not expressing the estrogen receptor, progesterone ...